After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more

StreetInsider2021-09-10

After-Hours Stock Movers: IVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

HENRYCSC
2021-09-10
HENRYCSC
👌
SanWangtikup
2021-09-10
SanWangtikup
Like pls
小虎一飞冲天
2021-09-10
小虎一飞冲天
Like pls. Thanks.
五个老乡
2021-09-10
五个老乡
`@挚文集团
Mhong
2021-09-10
Mhong
Like & comment
- kenong62:
  done
Ahlec
2021-09-10
Ahlec
Sold my affirm early [流泪]

发表看法

249

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2166479623?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-09-10 07:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2166479623","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18924599\">网页链接</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: IVERIC bio,Apellis Pharmaceuticals,Affirm and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 07:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18924599><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18924599\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APLS","symbol_name":"Apellis Pharmaceuticals Inc.","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=18924599","article_id":"2166479623","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2166479623","pubTimestamp":1631231042,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\n","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"APLS":"Apellis Pharmaceuticals Inc.","AFRM":"Affirm Holdings, Inc.","KPLT":"Katapult Holdings, Inc.","COOK":"Traeger Inc. (TGPX Holdings I LLC)","ZUMZ":"Zumiez Inc","ISEE":"IVERIC bio Inc"},"translate_title":"盘后股票市场：IVERIC bio、Apellis Pharmaceuticals、Affirm等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFRM":0.9,"APLS":0.9,"COOK":0.9,"ISEE":0.9,"KPLT":0.9,"ZUMZ":0.9},"content_text":"After-Hours Stock Movers:\nIVERIC bio (NASDAQ: ISEE) 47.9% HIGHER; gains following data from Apellis\nApellis Pharmaceuticals, Inc. (Nasdaq: APLS) 31.9% LOWER; reported top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan, an investigational targeted C3 therapy, in 1,258 adults with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). OAKS met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% (p=0.0003) and 16% (p=0.0052), respectively, compared to pooled sham at 12 months. DERBY did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% (p=0.0528) and 11% (p=0.0750) with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.\nAffirm Holdings, Inc. (NASDAQ: AFRM) 20.8% HIGHER; reported Q4 EPS of ($0.48), $0.19 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $261.8 million versus the consensus estimate of $225.29 million. Affirm Holdings, Inc. sees Q1 2022 revenue of $240-250 million, versus the consensus of $233.9 million. Affirm Holdings, Inc. sees FY2022 revenue of $1.16-1.19 billion, versus the consensus of $1.17 billion.\nKatapult Holdings, Inc. (NASDAQ: KPLT) 12.2% HIGHER; gains on AFRM results.\nTraeger, Inc. (NYSE: COOK) 9.8% LOWER; reported Q2 EPS of ($0.05), versus $0.17 reported last year. Revenue for the quarter came in at $213 million, versus $153.2 million reported last year. Traeger, Inc. sees FY2021 revenue of $760-770 million. Adjusted EBITDA is expected to be between $103 million and $108 million\nCedar Realty Trust (NYSE: CDR) 8.5% HIGHER; announced that its Board of Directors has initiated a dual-track process to review the Company's strategic alternatives in order to maximize shareholder value. As part of this process, Cedar is exploring, among other alternatives, a potential sale or merger involving the entire Company, and alternatively the potential sale of its core grocery-anchored shopping center portfolio and its mixed-use redevelopment projects.\nAmerican Outdoor Brands (NASDAQ: AOUT) 5.9% HIGHER; reported Q1 EPS of $0.48, $0.08 better than the analyst estimate of $0.40. Revenue for the quarter came in at $60.8 million versus the consensus estimate of $57.35 million. American Outdoor Brands sees FY2022 EPS of $2.02-$2.26, versus the consensus of $2.21. American Outdoor Brands sees FY2022 revenue of $280-295 million, versus the consensus of $291 million.\nSumo Logic Inc. (NASDAQ: SUMO) 6.3% LOWER; reported Q2 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $56.69 million. Sumo Logic Inc. sees Q3 2022 EPS of ($0.14), versus the consensus of ($0.15). Sumo Logic Inc. sees Q3 2022 revenue of $60.3-61.3 million, versus the consensus of $60.05 million. Sumo Logic Inc. sees FY2022 EPS of ($0.52)-($0.51), versus the consensus of ($0.56). Sumo Logic Inc. sees FY2022 revenue of $236.8-238.8 million, versus the consensus of $235.02 million\nCano Health (NYSE: CANO) 2.2% HIGHER; Cowen initiates coverage with an Outperform rating and a price target of $18.00.\nZumiez, Inc. (NASDAQ: ZUMZ) 5.3% LOWER; reported Q2 EPS of $0.94, $0.16 better than the analyst estimate of $0.78. Revenue for the quarter came in at $268.7 million versus the consensus estimate of $279.79 million.\nClover Health (NASDAQ: CLOV) 2.6% LOWER; Cowen analyst Gary Taylor initiates coverage with an Underperform rating and a price target of $7.00.\nEditas Medicine (NASDAQ: EDIT) 2.2% HIGHER; Oppenheimer upgraded from Perform to Outperform with a price target of $80.00 (from $42.00).\nTake-Two Interactive Software, Inc. (NASDAQ: TTWO) 2.5% LOWER; reiterated its outlook for its fiscal year 2022, ending March 31, 2022, which was originally provided on May 18, 2021 and reiterated on August 2, 2021. The Company’s wholly-owned label, Rockstar Games, has announced that the expanded and enhanced versions of Grand Theft Auto V and Grand Theft Auto Online for PlayStation 5 and Xbox Series X|S, which had been planned for release on November 11, 2021, are now planned to launch in March 2022 to allow additional time to further polish the final products.\nZscaler (NASDAQ: ZS) 2.4% HIGHER; reported Q4 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $197.1 million versus the consensus estimate of $186.82 million. Zscaler sees Q1 2022 EPS of $0.12, versus the consensus of $0.12. Zscaler sees Q1 2022 revenue of $210-212 million, versus the consensus of $199.7 million. Zscaler sees FY2022 EPS of $0.52-$0.56, versus the consensus of $0.56. Zscaler sees FY2022 revenue of $940-950 million, versus the consensus of $905.8 million.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":883240888,"gmtCreate":1631247875644,"gmtModify":1632883650960,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575091428590185","authorIdStr":"3575091428590185"},"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883240888","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883253116,"gmtCreate":1631247094735,"gmtModify":1632883655835,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087452914358580","authorIdStr":"4087452914358580"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883253116","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883259145,"gmtCreate":1631246952987,"gmtModify":1631889604508,"author":{"id":"3582098623642517","authorId":"3582098623642517","name":"小虎一飞冲天","avatar":"https://static.tigerbbs.com/1a55a61195830e019abf5d3cc69681b9","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3582098623642517","authorIdStr":"3582098623642517"},"htmlText":"Like pls. Thanks.","listText":"Like pls. Thanks.","text":"Like pls. Thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883259145","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883266257,"gmtCreate":1631245242179,"gmtModify":1631249668928,"author":{"id":"3576259559844048","authorId":"3576259559844048","name":"五个老乡","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3576259559844048","authorIdStr":"3576259559844048"},"htmlText":"`<a href=\"https://laohu8.com/U/4093065077764910\">@挚文集团</a>","listText":"`<a href=\"https://laohu8.com/U/4093065077764910\">@挚文集团</a>","text":"`@挚文集团","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883266257","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":883236838,"gmtCreate":1631242300024,"gmtModify":1631887814745,"author":{"id":"3578449123371823","authorId":"3578449123371823","name":"Mhong","avatar":"https://static.tigerbbs.com/f1110c90505cf18cc129130892c4dc2a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578449123371823","authorIdStr":"3578449123371823"},"htmlText":"Like &amp; comment","listText":"Like &amp; comment","text":"Like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883236838","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5814584,"gmtCreate":1631242411263,"gmtModify":1631887814748,"authorId":3574928367638029,"author":{"id":3574928367638029,"idStr":"3574928367638029","authorId":3574928367638029,"name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883236838,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":883207595,"gmtCreate":1631241291417,"gmtModify":1631885117638,"author":{"id":"4091753544363040","authorId":"4091753544363040","name":"Ahlec","avatar":"https://static.tigerbbs.com/81afb03fdd19de870e28208208ff7909","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4091753544363040","authorIdStr":"4091753544363040"},"htmlText":"Sold my affirm early&nbsp;[流泪]&nbsp;","listText":"Sold my affirm early&nbsp;[流泪]&nbsp;","text":"Sold my affirm early [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883207595","repostId":2166479623,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":249,"commentSize":33,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2166479623"}